Kwara moves to produce own brand of antimalaria tablets, suspension ‘KWAMAL’

The Kwara State Hospital Management Board has announced its move to commence the production of its own brand of antimalaria tablets and suspension ‘KWAMAL’.

“We have been working very hard to make this project a reality. We see a bright light at the end of the tunnel for our dear state to have its brand of pharmaceuticals,” a statement jointly signed by the Press Secretary and Assistant Press Secretary of the Board, Zulu-Gambari Halimat and Okanlawon Ramat, said.

The statement quoted the Executive Secretary of KW-HMB, Dr. Abdulraheem Malik, as saying that the objective of the project is to make quality healthcare affordable to the people of Kwara State in line with the vision of Governor AbdulRahman AbdulRazaq.

“With the support and encouragement of His Excellency and all other stakeholders, the Hospital Management Board will make this ambitious project a reality.

“This will reduce part of the capital flight Kwara State is presently experiencing in the pharmaceutical market and jobs will be created all over Nigeria since we plan to distribute nationwide so as to attract capital into our state. We want to put Kwara State in every household in Nigeria,” the Executive Secretary said.


Ibrahim Sheriff is the Editor of Fresh Insight and former Special Assistant on Media to the Speaker, Kwara state House of Assembly. Although a management science researcher by training, he has over five years experience of practice in Journalism, Public Relations and Communication Strategy. Sheriff holds a Masters Degree in Finance and Bachelors Degree in Banking and Finance from Kwara state University, Malete. He has Certificates in Digital Journalism, Enterprise Creation and Skill Acquisition (ECSA) and Basic Econometrics Data Analysis, as well as Bank of Industry (BoI) Certificate in Business Management. He is also a holder of Diploma in Cooperative Studies from Kwara state Polytechnic, Ilorin.

Learn More →